Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Orlando EJ, Han X, Tribouley C, Wood PA, Leary RJ, Riester M, Levine JE, Qayed M, Grupp SA, Boyer M, De Moerloose B, Nemecek ER, Bittencourt H, Hiramatsu H, Buechner J, Davies SM, Verneris MR, Nguyen K, Brogdon JL, Bitter H, Morrissey M, Pierog P, Pantano S, Engelman JA, Winckler W. Orlando EJ, et al. Among authors: nguyen k. Nat Med. 2018 Oct;24(10):1504-1506. doi: 10.1038/s41591-018-0146-z. Epub 2018 Oct 1. Nat Med. 2018. PMID: 30275569
Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial.
Jabbour E, Gökbuget N, Advani A, Stelljes M, Stock W, Liedtke M, Martinelli G, O'Brien S, Wang T, Laird AD, Vandendries E, Neuhof A, Nguyen K, Dakappagari N, DeAngelo DJ, Kantarjian H. Jabbour E, et al. Among authors: nguyen k. Leuk Res. 2020 Jan;88:106283. doi: 10.1016/j.leukres.2019.106283. Epub 2019 Nov 25. Leuk Res. 2020. PMID: 31790983 Free article. Clinical Trial.
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
Pulsipher MA, Han X, Maude SL, Laetsch TW, Qayed M, Rives S, Boyer MW, Hiramatsu H, Yanik GA, Driscoll T, Myers GD, Bader P, Baruchel A, Buechner J, Stefanski HE, Kalfoglou C, Nguyen K, Waldron ER, Thudium Mueller K, Maier HJ, Kari G, Grupp SA. Pulsipher MA, et al. Among authors: nguyen k. Blood Cancer Discov. 2022 Jan;3(1):66-81. doi: 10.1158/2643-3230.BCD-21-0095. Epub 2021 Dec 1. Blood Cancer Discov. 2022. PMID: 35019853 Free PMC article.
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry.
Tettero JM, Dakappagari N, Heidinga ME, Oussoren-Brockhoff Y, Hanekamp D, Pahuja A, Burns K, Kaur P, Alfonso Z, van der Velden VHJ, Te Marvelde JG, Hobo W, Slomp J, Bachas C, Kelder A, Nguyen K, Cloos J. Tettero JM, et al. Among authors: nguyen k. Cytometry B Clin Cytom. 2023 Nov;104(6):426-439. doi: 10.1002/cyto.b.22144. Epub 2023 Sep 28. Cytometry B Clin Cytom. 2023. PMID: 37766649 Free article.
Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22.
Kantarjian HM, Stock W, Cassaday RD, DeAngelo DJ, Jabbour E, O'Brien SM, Stelljes M, Wang T, Paccagnella ML, Nguyen K, Sleight B, Vandendries E, Neuhof A, Laird AD, Advani AS. Kantarjian HM, et al. Among authors: nguyen k. Clin Cancer Res. 2021 May 15;27(10):2742-2754. doi: 10.1158/1078-0432.CCR-20-2399. Epub 2021 Feb 18. Clin Cancer Res. 2021. PMID: 33602684
Association between underlying health conditions and long COVID among non-hospitalized and hospitalized individuals as modified by health literacy: A multi-center study.
Vo HT, Dao TV, Do TX, Do BN, Nguyen TT, Pham KM, Vu VH, Pham LV, Nguyen LTH, Le LTH, Nguyen HC, Tran TV, Nguyen TH, Nguyen AT, Nguyen HV, Nguyen PB, Pham TTM, Dao TD, Le TT, Nguyen TTP, Tran CQ, Nguyen KT, Duong TV. Vo HT, et al. Among authors: nguyen kt. Public Health. 2025 Jan 10;239:87-93. doi: 10.1016/j.puhe.2024.12.032. Online ahead of print. Public Health. 2025. PMID: 39798220
Country-specific key lifestyle factors and health outcomes for resource allocation in the general population: a network analysis across 29 countries.
Li J, Fong DYT, Lok KYW, Wong JYH, Ho MM, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N. Li J, et al. Among authors: nguyen kt. J Glob Health. 2025 Jan 10;15:04011. doi: 10.7189/jogh.15.04011. J Glob Health. 2025. PMID: 39791329 Free PMC article.
Social network analysis as a new tool to measure academic impact of physicians.
Vivek N, Clark E, Gao L, Xu S, Baskauf S, Nguyen K, Goldin M, Prasad K, Miller A, Zhang P, Yang S, Rohde S, Topf M, Gelbard A. Vivek N, et al. Among authors: nguyen k. Laryngoscope Investig Otolaryngol. 2025 Jan 7;10(1):e70060. doi: 10.1002/lio2.70060. eCollection 2025 Feb. Laryngoscope Investig Otolaryngol. 2025. PMID: 39780864 Free PMC article.
4,387 results